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1. Introduction 
Anal fissures are common in infancy and represent the most common cause of bright rectal 
bleeding at any age. Delayed diagnosis and treatment can lead to a disturbing cycle of 
constipation, repeat rectal bleeding, and crying, due to increasing pain during and after 
defecation. In spite of its high frequency, the problem remains underrated by most 
clinicians, with only a paucity of data on the management of anal fissures in children being 
found in the literature. The objective of this work is to bring this common and distressing 
problem into a more positive light, based on our good results achieved by the nifedipine gel 
with lidocaine treatment.  
2. History 
The first description of anal sphincterotomy in the world literature is found in Alexis Boyer's 
11-volume Traite des Maladies Chirurgicales published between 1818 and 1826 (DeMoulin, 
1977). His descriptions of the condition are dramatic, detailing the severe suffering patients 
endured. Louis Lemmonier, in 1869, gave the world the first anatomic description of an anal 
fissure. Boyer established the relationship between anal sphincter spasm and no healing of 
anal fissures, as well as the association between constipation and anal fissure. He was the 
first to divide the sphincter to cure the problem. This procedure, routine and quite safe 
today, caused deaths and pelvic abscesses in four patients, as reported by Velpeau in 1832. 
During the 1950s, fissure excision, anal sphincter stretching, injection therapy (local 
anesthetic and sclerotherapy) and sphincterotomy were performed for chronic anal fissures. 
Later, in the late 1960s and early 1970s, cutaneous island advancement flaps were added to 
this group (Ruiz-Moreno, 1968; Samson & Stewart, 1970). The modern reintroduction of 
sphincterotomy for anal fissure can be attributed to Eisenhammer (1951). In 1953, Inburg 
published his technique of partial internal sphincterotomy, cutting the sphincter through the 
bed of the fissure. It was not until the mid to late 1970s that lateral internal sphincterotomy 
became accepted as the standard of care to treat anal fissures surgically (J. Nelson, 2006).  
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3. Definition 
An anal fissure is a linear, longitudinal split in the lining of the distal anal canal, extending 
from below the dentate line to the anal verge. They are usually very painful because of their 
somatic innervations, the pain resulting from spasm of the anal sphincter in response to 
stretching and tearing during passage of stool. A well developed anal fissure rests directly 
over the internal sphincter and the circular fibers of this sphincter are visible on the floor of 
the fissure on naked eye inspection.  
4. Anatomy 
ANAL FISSURE - ANATOMY
 
Fig. 1. Anal fissure anatomy. 
5. Incidence and etiology 
Anal fissures presents mostly in children aged 6-24 months. The overall incidence in 
children is not well described. Anal fissures are located in the posterior midline in 90% of 
the cases, although 10-20% in women and 1-10% in men are located in the anterior midline 
(Notaras, 1988). The posterior commissure of the anoderm is less well perfused than other 
anodermal regions (Schouten et al., 1994). Pressure over the branches of the inferior rectal 
artery (increased tone at the internal sphincter and high canal pressures) causes relative 
ischemia (Klosterhalfen et al., 1989). First described as a disease entity in 1934, the cause of 
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anal fissures is still unknown. Constipation and passage of hard stool were traditionally 
blamed and believed to be the causative factor of anal fissure, but a history of constipation is 
elicited in only approximately 20% of the patients (McCallion & Gardiner, 2001). Trauma, 
usually because of passage of a large or hard stool, is believed to be a common initiating 
factor. Ball suggested that passage of hard stool tore down the anal valve, leaving the coiled-
up skin at the anal verge as the "sentinel pile" (Lund & Scholefield, 1996). The remaining 
fissures are associated with chronic diarrhea, food allergy, Crohn's disease, syphilis, human 
immunodeficiency virus (HIV), or tuberculosis.  
6. Pathophysiology 
The pathophysiology is fairly complex and multifactorial, with anodermal ischemia, 
infection, chronic constipation, hypertonicity of the smooth muscle of the internal anal 
sphincter (IAS) and elevated maximal anal resting pressure (MARP) being involved (Gillet 
& Padias, 2006; Schouten et al., 1996). The exact mechanism surrounding the 
pathophysiology of anal fissures has not been clearly established, but current theories 
involve the tonicity of the anal sphincter and anal blood flow. A relative lack of nitrate oxide 
synthase, as found in other spasmodic states of the gastrointestinal tract, has been suggested 
as a possible mechanism for IAS hypertonia (Lund, 2006). As fissures are most commonly 
seen in the posterior midline, inadequate blood flow to this region has been hypothesized to 
play a role in the development of fissures. End arterioles from the inferior rectal artery 
pierce both sphincters to reach the submucosa of the anal canal and travel cephalad in this 
plane. Klosterhalfen et al. (1989) suggested that hypertonic sphincter decreases blood flow in 
these terminal vessels as they pass through the IAS fibers. Recognized features common to 
most chronic anal fissures are a high resting anal canal pressure due to hypertonicity of the 
internal anal sphincter, reduced vascular perfusion index at the site of the fissure, and the 
presence of "ultraslow" pressure wave activity in the internal anal sphincter (Hancok, 1977, 
Schouten & Blankensteijn, 1992).  
7. Classification 
Anal fissures may be classified as acute or chronic and typical or atypical. Acute fissures 
cause bright red bleeding with bowel movements and anal pain or spasm that can last for 
hours after the bowel movement. They have the appearance of a simple tear, superficial or 
deep in the anoderm. Chronic anal fissures present with induration at the edges, a sentinel 
pile, visible fibers of the internal anal sphincter, chronic granulation tissue in the base of the 
fissure and a hypertrophied anal papilla. They are acute fissures that fail to heal following 6 
to 8 weeks of intensive treatment. Typical fissures are usually in the posterior or anterior 
midline, and are not associated with other diseases. Atypical fissures can occur anywhere in 
the anal canal, and tend to be associated with other diseases.  
8. Differential diagnosis 
Pruritus ani, inflammatory bowel disease (mostly Crohn's disease), tuberculosis, immune 
system diseases, acquired immunodeficiency syndrome (AIDS), Chlamydia, venereal 
diseases, neoplasm, and sexual abuse.  
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9. Innervation and pharmacology of the internal sphincter 
The enteric nervous system consists of two major plexuses of interconnecting ganglia, the 
myenteric (Auerbach's) plexus and the submucous (Meissner's) plexus. The enteric nervous 
system contains entire reflex pathways that permit peristaltic contractions independent of 
extrinsic innervations. The internal anal sphincter receives its sympathetic innervations from 
the hypogastric pelvic plexuses. Parasympathetic innervation is from the first, second, and 
third sacral segments via the pelvic plexus. Internal anal smooth muscle relaxation can be 
inhibited by stimulation of nonadrenergic noncholinergic enteric neurons, parasympathetic 
muscarinic receptors, or sympathetic beta adrenoceptors, and by inhibition of calcium entry 
into the cell. Sphincter contraction depends on an increase in cytoplasmic calcium and is 
enhanced by sympathetic alpha adrenergic stimulation (Bhardwaj et al., 2000). A number of 
putative nonadrenergic transmitters have been suggested, the work being concentrated on the 
function of adenosine triphosphate (ATP), vasoactive intestinal peptide (VIP), and nitric oxide 
(NO) and their role in mediating the rectoanal inhibitory reflex (RAIR), as they are known to 
act together in mediating enteric inhibitory cotransmission in other areas of the gut. NO 
activates soluble guanylate monophosphate (cGMP) and relaxation of smooth muscle. NO has 
been widely demonstrated to be the main chemical neurotransmitting agent in the 
nonadrenergic neurons mediating relaxation of the internal anal sphincter. Working on the 
opposum internal anal sphincter, Rattan and Chakder suggested that NO was a nonadrenergic 
noncholinergic inhibitory neurotransmitter (Rattan & Chakder, 1992). NO caused 
tetrodotoxin-resistant relaxations of internal anal sphincter strips. The internal anal sphincter 
generates a high degree of tone in the resting state and is responsible for 50-85% of overall 
resting anal tone. This is due to both intrinsic myogenic activity and extrinsic adrenergic 
innervations. The effects of adrenergic agonists are well documented. Parks et al demonstrated 
that internal anal sphincter strips contracted to noradrenaline, had a variable response to 
adrenaline and relaxed in response to isoprenaline (Parks et al., 1969). Analysis of these 
responses using appropriate adrenoceptor antagonists has shown that contractions were 
mediated via alpha-receptors and relaxations via beta-receptors. Contractions to noradrenaline 
and adrenaline can be converted to relaxations by the addition of an alpha-receptor antagonist. 
Burleigh et al. (1979) have shown that acetylcholine has a predominantly inhibitory effect on 
internal anal sphincter smooth muscle acting through muscarinic receptors. Furthermore, 
electrical field stimulation of internal anal sphincter strips resulted in relaxation of the smooth 
muscle. These relaxations are abolished by tetrodotoxin, indicating that they are nerve 
mediated. Transient internal anal sphincter relaxation in response to rectal distension was first 
described by Gowers in 1877. O'Kelly et al. (1994) suggested that NO might be important in 
mediating the rectoanal inhibitory reflex. A review on the pharmacology of the internal anal 
sphincter was reported by Cook et al. (2001).  
10. Clinical picture 
The clinical picture involves a history of constipation in 20% of the cases, intense crying with 
bowel movements, streaks of bright red blood on the surface of hard stool, on the diaper, or 
on the toilet paper, following bowel movements, discharge and pruritus. The clinical 
hallmark of anal fissure is pain during, and especially some time after defecation. Inspection 
of the anal region reveals a posterior midline laceration, a sentinel skin tag, and signs of 
inflammation.  
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11. Medical treatment 
Acute fissures often resolve within 10-14 days of conservative management. However, as 
long as 6-8 weeks may be necessary for the fissure to heal. Recurrence after conservative 
management can be observed in 27% of the cases. Dietary modification (increased fluid and 
fiber intake), stool softeners (lactulose) and warm baths are all part of the conservative 
treatment (Shafik, 1993). Conservative treatment is safe, has few side effects, and should 
usually be the first step in therapy. Shub et al. (1978) reported that 44% of fissure patients 
healed with sitz baths, a psyllium fiber supplement, and emollient suppositories. In 27% of 
these "healed" patients, the fissures recurred over a 5-year follow-up period.  
The optimal treatment for an anal fissure is to induce a temporary reduction of anal canal 
resting pressure to allow healing of the fissure without permanently disrupting normal 
sphincter function. Internal anal smooth muscle relaxation can be inhibited by stimulation of 
non-adrenergic non-cholinergic enteric neurons, parasympathetic muscarinic receptors, or 
sympathetic beta adrenoceptors, and by inhibition of calcium entry into the cell.  
11.1 Glyceryl trinitrate 
Glyceryl trinitrate (GTN) is a vasodilator and causes relaxation of smooth muscle. 
Relaxation of the internal sphincter tone is achieved by the reduction of intracellular calcium 
in the smooth muscle cells by nitric oxide donation. Topical GTN heals anal fissures better 
than a placebo, irrespective of dose, but is associated with headache in around 25% of the 
patients. During the late 90's, GTN ointment was the best one could offer for a child with 
anal fissure. Exogenous nitrates release nitric oxide in vivo and have been used clinically as 
nitric oxide donors. Loder et al. (1994) demonstrated that topical application of 0.2% GTN 
led to decreased resting anal pressure. Chemical sphincterotomy using GTN with adjunctive 
stool softeners has been demonstrated to be quite effective at relieving symptoms and 
promoting healing. They significantly decrease pain during the therapy period. A study of 
80 patients reported in the Lancet in 1997 showed healing in 26/38 (68%) after GTN, 
compared with 3/30 (8%) after placebo (Lund & Scholefield, 1997). Another study 
comparing GTN, lidocaine and placebo, was reported in the Journal of Pediatric Surgery in 
1999. Complete healing was observed in 26/31 (83.9%) after GTN, 7/14 (50%) after 
lidocaine, and 6/11 (35.3%) after placebo (Tander et al., 1999). Kenny et al. (2001) questioned 
the healing power of GTN, reporting 31 children with an overall fissure healing rate of 84%, 
but with no differences being observed between GTN and placebo. Bacher et al. (1997) 
conducted a randomized trial of 0.2% GTN vs. 2% lidocaine gel, each applied 3 times daily, 
in a mixed group of acute and chronic fissure patients. After 1 month, healing rates were 
higher with GTN in both the acute (91.6%, GTN vs. 50%, lidocaine) and chronic (62.5%, GTN 
vs. 20%, lidocaine) fissure groups. A randomized, placebo-controlled treatment of anal 
fissure by lidocaine, EMLA, and GTN in 102 children, showed faster response rates by GTN 
application, and similar and high success rates by 8 weeks of EMLA treatment (Sönmez et 
al., 2002). The average age of patients was 3 years (range, 2.5 months to 15 years). Symptoms 
at admission consisted of hard stools in 90% of patients, pain or crying during defecation in 
87%, bleeding in 84%, excessive straining at defecation in 35%, and mucosal prolapse in 9%. 
Despite the encouraging results reported with topical nitrates, severe headaches and noted 
relapse rates are major drawbacks. Dorfman et al. (1999) reported a 27% symptomatic 
relapse rate (median follow-up, 6 months). Associated side-effects were observed in 78% of 
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patients, including headaches in 63% and light-headedness in 52%. Carapeti et al. (1999) 
noted relapse rates of 33% with 0.2% GNT and 25% with escalating-dose GTN (mean follow-
up, 9 months). Headaches were observed in 72% of the patients. More recent studies have 
shown lower healing rates with GTN than were initially reported. Patient non-compliance 
and tachyphylaxis are also major drawnbacks to this treatment. Local application of another 
precursor of nitric oxide, L-arginine, has been reported as effective in promoting fissure 
healing without headache as a side effect (Gosselink et al., 2005).  
11.2 Calcium channel blockers 
They improve fissure healing by inhibiting calcium ion entry through voltage-sensitive 
areas of vascular smooth muscle, causing muscle relaxation and vascular dilatation. Topical 
diltiazem (Cardizem) has similar efficacy to GNT, with fewer side effects, but the experience 
with children is small. 
11.3 Nifedipine  
NIFEDIPINE CHEMICAL STRUCTURE
 
Fig. 2. Nifedipine chemical structure. 
Nifedipine (Adalat) has a modulating effect on the microcirculation (Oshiro et al., 1995). The 
advent of this calcium channel blocker as nifedipine gel was a turning point and a major 
contribution to the healing of posterior anal fissures. Used to treat hypertension, angina 
pectoris, Raynaud's syndrome, congestive heart failure, and cardiomyopathies, it may cause 
side effects like headache, upset stomach, dizziness, tiredness, flushing, heartburn, 
tachycardia, muscle cramps, enlargement of gum tissue around teeth, constipation, nasal 
congestion, and cough. The first clinical study on the effects of calcium antagonists on resting 
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anal pressure showed that pressures were reduced with sublingual nifedipine in both healthy 
volunteers and patients with hypertonic sphincters (Chrysos et al., 1996). A medline database 
literature search concerning the non-surgical treatment of chronic anal fissures, including 282 
patients, called the attention to nifedipine gel. The study compared nifedipine with lidocaine 
with hydrocortisone acetate, showing 98% complete healing after nifedipine and 61% complete 
healing in the control group. Nifedipine reduced MRAP by 30% and maximum squeeze 
pressure by 16.8% (McCallion & Gardiner, 2001). Another large study by Perroti et al. (2002) 
comparing nifedipine and lidocaine with hydrocortisone and lidocaine, showed complete 
healing in 94.5% of the nifedipine treated patients and only 16.4% of the control patients.  
Preliminary results of a multicenter study on nifedipine for local use in conservative 
treatment of anal fissures was reported by Antropoli in 1999. Total remission from acute 
anal fissure was achieved after 21 days of therapy in 95% of the nifedipine-treated patients, 
with a mean reduction of 30% in maximum resting anal pressures. A randomized controlled 
double-blind trial comparing nifedipine gel plus lidocaine, topical lidocaine alone and 
hydrocortisone acetate ointment, showed topical nifedipine plus lidocaine gel to be effective 
and well tolerated in the treatment of chronic anal fissures (Perroti et al., 2002). In other 
studies reported by Merenstein & Rosenbaum (2003) and Slawson (2003), remarkable 
improvement in healing was observed when 1.5% lidocaine and 0.3% nifedipine were 
applied twice daily for 6 weeks. Ezra & Susmalliam (2003) showed a better healing rate with 
topical nifedipine than with GTN. Katsinelos et al. (2006) reported that aggressive treatment 
of acute anal fissure with 0.5% nifedipine gel ointment prevents its evolution to chronicity. 
Twenty-seven of their 31 patients achieved complete remission and healing of the anal 
fissure following an 8-week treatment course (85.2%). Recurrence was observed in 16% of 
their patients. A systematic review of medical therapy for anal fissure including 31 trials 
from 1966 to 2002 returned the black shadow of pessimism to most physicians' minds. Nine 
agents were studied: GTN, isosorbide dinitrate, botulinum toxin, diltiazem, nifedipine, 
hydrocortisone, lidocaine, bran, and placebo. The results were only marginally better than 
placebo (R. Nelson, 2004)! A Cochrane Collaboration Review from 2009, by the same author, 
showed no better results. GNT was found to be marginally, but significantly, better than 
placebo in healing anal fissure (48.6% vs. 37%, p < 0.004), but late recurrence of the fissure 
was common, in the range of 50% of those initially cured!  Botox and calcium channel 
blockers were equivalent to GNT in efficacy, with fewer adverse effects. No medical therapy 
was found to come close to the efficacy of surgical sphincterotomy (R.L. Nelson, 2006). 
Combined treatments have also been reported. The combination of nifedipine and 
botulinum toxin was superior to nitroglycerin and pneumatic dilatation with respect to both 
healing (94% v. 71%) and recurrence rate (2% v. 27%) (Tranqui et al., 2006). Headache is the 
most common complication of administering topical nifedipine in adults, but not in 
children. Nifedipine gel in the treatment of anal fissure has now been accepted even in 
China, with good results (Hong-yu et al., 2004). Reversible chemical sphincterotomy with 
nifedipine gel looks now as the most promising development in the treatment of anal 
fissures in children. The outcome is extremely good and side effects almost nonexistent.  
11.4 Botulinum toxin (Botox)  
Botulinum neurotoxin is a lethal biological substance produced by the anaerobic bacterium 
Clostridium botulinum. Serotype A is commercially available and has proven to be of 
therapeutic value in a variety of clinical conditions such as strabismus, torticollis, 
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hyperhidrosis, achalasia and chronic anal fissure (Jankovic & Brin, 1991). Botulinum toxin 
(Botox) is associated with a similar rate of healing of anal fissure as GTN, but is more 
expensive. The technique, dose and site of injection do not affect the rate of healing. The 
experience in children is very small. Jost & Schimrig (1993) first reported the use of botulin 
toxin (BT) for anal fissure in 1933. The commercially available agent prevents neural 
transmission by preventing acetylcholine release from presynaptic nerve terminals. BT 
exerts its effects on the acetylcholine releasing parasympathetic peripheral nerve endings as 
well as the ganglionic nerve endings, leading to flaccid paralysis of the internal anal 
sphincter (IAS). This effect stays for about 3 months, a period sufficient for most non-
complicated anal fissures to heal. Jost (1997) subsequently reported on a series of 100 
patients treated with BT injection. In all, 78 patients became pain-free within 3 days, and 
healing rates at 3 and 6 months were 82% and 79%. BT injection was compared with topical 
GTN (0.2% twice daily) in a randomized trial of 50 chronic anal fissure patients (Brisinda et 
al., 1999). Resting anal pressure decreased in both groups, but did so to a greater extent in 
the BT group (29% with BT vs. 14% with GTN at 2 months). Healing rates were 96% in the 
BT group and 60% in the GTN group. No adverse effects were seen in the BT group.  
11.5 Hyperbaric oxygen 
Hyperbaric oxygen therapy provides a significant increase in tissue oxygenation in 
hypoperfused wounds. This increase in oxygen tension induces positive changes in the wound 
repair process by enhancing fibroblast replication, collagen synthesis and neovascularization. 
Cundall et al. (2003) reported a small series of adult patients with chronic anal fissure treated 
by hyperbaric oxygen. They found the procedure safe and appropriate in patients who have 
failed medical treatment, in those at risk of fecal incontinence, and in patients who are unfit for 
operation or in whom surgery has failed (Cundall et al., 2003).  
11.6 Naturopathic treatment 
Homeopathic medicines are excellent to alleviate the pain and spasm. Some of the more often 
indicated medicines are Chamomilla, Graphites, Nitric acid, Ratanhia, Sepia, Silicea and Thuja. 
Aesculus and Paeonia may be indicated if keynote symptoms are present. Homeopathic 
medicines often work faster and provide greater pain relief than analgesics and narcotics. In 
order to facilitate healing of the fissure, a topical cream consisting of Vitamins A and E, 
panthenol, calendula, goldenseal and Emu oil , can be used (Kruzel, 2006).  
11.7 Iontophoresis 
Iontophoresis using a zinc or copper electrode and applying a positive current will help to 
facilitate healing by hardening the underlying fissure, decreasing bleeding and affording 
pain relief.  
11.8 Nd:YAG or CO2 laser 
Contact Nd:YAG laser therapy appears to be efficient and safe in the treatment of anorectal 
lesions, including anal fissures (Sankar & Joffe, 1988; Walfisch et al., 1994). With the advent 
of the CO2 laser, a laser sphincterotomy and fissurectomy have proved to be very effective, 
with good results, prompt rehabilitation, reduced amount of complications and fewer 
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recurrences (Ali, 1988; Skobelkin et al., 1989). It involves laser vaporization of the fissure 
locally. Patient acceptance is remarkable, and the treatment can be carried out at a fraction 
of the cost of hospital surgical treatment. There are no reports of laser treatment for anal 
fissures in children.  
11.9 Wonder remedies 
 
Fig. 3a. Anal Fissures DX: a unique formula with anti-inflammatory properties, providing 
immediate soothing relief. 
 
Fig. 3b. H-Fissures: healing natural oil with anti-inflammatory properties, specially 
formulated to provide instant relief from the pain and discomfort of fissures, reducing the 
swelling without skin irritation. 
 
Fig. 3c. Fissure Control: a breakthrough topical homeopathic treatment made of a blend of 
herbs (Chamomile, Lavandula Angustifolia, Helichrysum, and Hamamelis Virginiana). 
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Fig. 3d. Paeonia-Heel: a homeopathic medicine containing Paeonia officinalis (Peony), 
Graphites (graphite), Nux vomica (vomit nut), Sulfur (sulphur), Acidum nitricum (nitric 
acid), and Hamamelis (witch-hazel). 
 
Fig. 3e. Dr Wheatgrass's cream: enriched with highly bioactive wheatgrass-derived 
antioxidants, containing vitamins A,C and E, phytosterols, aminoacids and minerals. The 
Figure shows Dr Wheatgrass's antioxidant skin recovery cream.  
 
Fig. 3f. Nature's Wonderland Stone Root Herbal Supplement: Collinsonia Canadensis, sour 
and spicy in taste, and warming in action. It relaxes constriction and clears venous 
congestion and inflammation. The Figure shows the Collinsonia Canadensis flowers.  
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12. Surgical treatment 
Surgical treatment is rarely needed for infants and children. Open or closed lateral internal 
sphincterotomy (healing rates of 93% to 100%, recurrence rates of 0% to 25%), internal 
sphincterotomy (for chronic anal fissures), and posterior midline sphincterotomy are all part 
of the surgical arsenal. The open lateral sphincterotomy is the procedure of choice for 
children. Relative contraindications to operative treatment include inflammatory bowel 
disease and profound immunosupression.  
12.1 Anal dilatation 
First described in 1829 by Recamier and popularized by Lord in the treatment of 
hemorrhoids, anal stretching has been used in the past based on the concept of loosening the 
sphincter muscle and increasing the blood flow to the anoderm. Anal dilatation was 
reintroduced for anal fissure therapy in 1964, with success rates of 87% to 100% (Watts et al., 
1964), but are not recommended in children because of the very high rate of recurrence (10% 
- 30%) , risk of sphincter damage and incontinence after excessive stretching.  
12.2 Fissurectomy 
Fissurectomy as a treatment for anal fissures in children was found successful only when 
combined with postoperative laxative therapy (Lambe et al., 2000a). An important part of 
their technique was the use of stay sutures to avoid the need for an anal retractor, thereby 
preventing stretching of the internal anal sphincter. A triangular part of the anoderm is 
excised along with the fissure itself. A good and reliable operation, but leaves behind a large 
and uncomfortable external wound, which takes a long time to heal. Application of a split 
thickness graft to the wound has been advocated, in order to improve healing.  
12.3 Internal anal sphincterotomy 
Internal anal sphincterotomy (IAS) was popularized for the treatment of anal fissure during 
the 1950s by Eisenhammer (1951). Lateral internal sphincterotomy (LIS) has been found to 
be the preferred operation. LIS can be performed using either the open or closed technique , 
the method of Notaras, dividing the IAS via a small stab wound (Notaras, 1971). Equal 
success has been reported with open or closed lateral sphincterotomy for acute and chronic 
anal fissures in children. A systematic review on the treatment of anal fissure was published 
by Steele & Madoff in 2006. Current concepts in anal fissures were reported by Ayantude et 
al. (2006) in the same year, involving a literature search from 1970 to 2004.  
Chronic anal fissures tend to be refractory and are usually reluctant to heal with 
conservative treatment. Chronicity is defined by chronology (6-8 weeks) and morphologic 
features (visible transverse internal anal sphincter fibers, chronic granulation tissue, 
indurated edge, a sentinel pile, and a hypertrophic anal papilla). A very large series of adult 
patients was published by Lysy et al. in 2006. Prolonged periods of treatment were 
necessary and 384 patients were healed (84.4%) by the end of four months. Older age and 
longer time interval between symptom appearance and treatment negatively affected fissure 
healing. The explanation for the latter was that longer time exposure of the fissure area to 
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inflammation and ischemia and subsequent fibrosis may compromise the healing process. 
After recurrence, patient education for self and prompt retreatment was found to improve 
outcome. Chronic anal fissures are caused by internal sphincter hypertonia, which leads to 
reduced blood flow and tissue hypoxia, with consequent healing failure. A cautious surgical 
approach is required to treat those who do not respond to medical treatment, and should 
include excision of the fissure along with its sentinel tag and internal sphincterotomy at the 
base of the ulcer (Cohen & Dehn, 1995; Lambe et al., 2000b). The wound is left open and 
should heal in 7-14 days without scarring. Local reconstruction with advancement flaps is a 
relatively new and effective adjunct to chronic fissure excision. Practice parameters for the 
management of anal fissures from the American Society of Colon and Rectal Surgeons were 
reported by Orsay et al. (2004) and a very extensive review on the diagnosis and care of 
patients with anal fissure was reported by the American Gastroenterological Association 
(Madoff & Fleshman, 2003).  
13. Our experience: Nifedipine gel 0.2% with lidocaine 
13.1 Subjects  
Seventy children suffering from acute and chronic anal fissures treated by us between 2004 
and 2010 comprised the study population. They were all treated topically with nifedipine 
gel 0.2% with lidocaine for 4 weeks and followed up for as long as possible in our outpatient 
clinic (a maximum of 5 years).  
13.2 Methods 
Because anal fissure has such a distinctive appearance, its healing is the most objective 
measure of treatment efficacy available that can be standardized. Combining all analyses in 
which a placebo was used as the comparison group, the healing rate in the placebo group is 
35.5 percent, a level of response that is fairly uniform across studies (standard deviation, 
11.8 percent). For these reasons we did not find necessary to use a control group in the 
present pilot study.  
13.3 Results 
There were 28 males and 42 females. Their clinical presentation consisted of constipation, 
rectal bleeding, anal and abdominal pain, perianal itching and rectal prolapse (58, 50, 33, 6, 
4, and 1 cases, respectively). Posterior, anterior, multiple, both posterior and anterior, and 
both posterior and lateral fissures were the main physical findings (44, 16, 5, 4, and 1 cases, 
respectively). Fifty eight patients completed the 4-week treatment course, with another 7 
patients requiring a second 4-week treatment course in order to achieve complete remission, 
indicated by resolution of symptoms and complete healing of the fissure (65 patients 
altogether). The remaining 5 patients had recurrence of symptoms in 2, 4, 11, 18 and 19 
months, respectively, treated successfully by an additional 4-week course of nifedipine. The 
recurrence rate observed was very low (7.14%). All the 70 patients had a mean follow-up of 
1.88 years, ranging from 6 months to 5.2 years. Problems with compliance were not 
observed, one of the main reasons for treatment failure in adults. No side effects of 
nifedipine were observed.  
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Fig. 4. Clinical presentation (percentage) 
14. Special situations 
1. Crohn's disease: Platell et al. (1996) noted symptomatic anal pathology in 42.4% of 
Crohn's disease patients, 27.6% of them presenting anal fissures. Frequently, they are 
multiple or off the midline, and often coexist with other pathology (Sangwan et al., 
1996). They can be locally aggressive, progressing to form deep ulcers with granulating 
bases and overlapping skin edges.  
2. HIV/AIDS: Anal fissures maintain their typical appearance, but have poor wound 
healing (Lord, 1997). Barrett et al. (1998) reported their experience with perianal disease 
in 260 HIV-positive patients, 32% of them with anal fissures (Barrett et al., 1998). 
Eighteen patients underwent sphincterotomies. Viamonte et al. (1993) reviewed the 
treatment of 33 HIV-positive fissure patients. Thirteen underwent LIS, with excellent 
results (12 improved).  
15. Conclusions 
Topical 0.2% nifedipine with lidocaine appears today as the most efficient mode of 
treatment for anal fissures in children, with a significant healing rate and no side effects. It is 
safe and effective, prevents the evolution of acute anal fissures in children to chronicity, 
avoids surgical procedures in the great majority of cases, avoids complications and does not 
require hospitalization.  
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Fig. 5. Efficacy of medical treatment. 
 
Fig. 6. Fissure location 
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